nifedipine has been researched along with Airway Obstruction in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients suffering from angina pectoris with co-existing fixed or labile airways obstruction, were administered fortnightly treatment periods of nifedipine or matching placebo over an 8-week period." | 9.05 | Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction. ( Chatterjee, SS; Jaiprakash, SS; MacDonald, G; Sahay, JN, 1980) |
| "RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1, 1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent." | 7.68 | Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker. ( Ahmed, T; Anderson, DW; Capetola, RJ; Dodd, JH; Kirchner, T; Moore, JB; Ritchie, DM, 1993) |
| "Twenty patients suffering from angina pectoris with co-existing fixed or labile airways obstruction, were administered fortnightly treatment periods of nifedipine or matching placebo over an 8-week period." | 5.05 | Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction. ( Chatterjee, SS; Jaiprakash, SS; MacDonald, G; Sahay, JN, 1980) |
| "RWJ 22108 (N-benzyl-N-methylaminoethyl 9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1, 1-dioxothiacyclohepteno-[3,2-b]pyridine-8-carboxylate) is a new bronchoselective calcium entry blocker with potential use as an antiasthmatic agent." | 3.68 | Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker. ( Ahmed, T; Anderson, DW; Capetola, RJ; Dodd, JH; Kirchner, T; Moore, JB; Ritchie, DM, 1993) |
| " The dosage and choice of drugs are based on pharmaco-kinetic and dynamic data in animals and man." | 2.36 | Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview. ( Oh, VM, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, VM | 1 |
| Jaiprakash, SS | 1 |
| Sahay, JN | 1 |
| Chatterjee, SS | 1 |
| MacDonald, G | 1 |
| Ritchie, DM | 1 |
| Kirchner, T | 1 |
| Moore, JB | 1 |
| Dodd, JH | 1 |
| Ahmed, T | 1 |
| Anderson, DW | 1 |
| Capetola, RJ | 1 |
1 review available for nifedipine and Airway Obstruction
| Article | Year |
|---|---|
Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Airway Obstruction; Angina Pectoris; Anti | 1980 |
1 trial available for nifedipine and Airway Obstruction
| Article | Year |
|---|---|
Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction.
Topics: Adult; Aged; Airway Obstruction; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Female; | 1980 |
1 other study available for nifedipine and Airway Obstruction
| Article | Year |
|---|---|
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker.
Topics: Airway Obstruction; Airway Resistance; Animals; Antigens; Asthma; Bronchial Spasm; Bronchoconstricti | 1993 |